Regulators need to pay more attention to controlling CRISPR, the revolutionary gene-editing tool, says Jennifer Doudna.One year on: Doudna, a Unive...
MIT Technology Review · 16 Nov 2019
Join 3000+ others receiving my regular newsletter:
